p53-induced apoptosis as a safeguard against cancer

被引:68
作者
Asker, C
Wiman, KG [1 ]
Selivanova, G
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden
[2] Karolinska Inst, Canc Ctr Karolinska, SE-17177 Stockholm, Sweden
关键词
D O I
10.1006/bbrc.1999.1446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 acts as a potent tumor suppressor largely through its ability to induce cell death by apoptosis. Diverse cellular stress conditions, e.g., DNA damage, hypoxia, and oncogene activation, trigger p53-dependent apoptosis. ARF is a 14-kDa protein encoded by an alternative reading frame within the human INK4a locus that also encodes the p16 protein. ARF induces p53 in response to oncogene activation by preventing its degradation. This ensures the elimination of emerging tumor cells by p53-dependent apoptosis. p53 promotes apoptosis through multiple mechanisms, including transactivation of specific target genes, down-regulation of a distinct set of genes, and transcription-independent mechanisms. This may explain the frequent inactivation of ARF/p53 rather than downstream effecters during tumor development. (C) 1999 Academic Press.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 88 条
  • [61] Reactivation of mutant p53: a new strategy for cancer therapy
    Selivanova, G
    Kawasaki, T
    Ryabchenko, L
    Wiman, KG
    [J]. SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) : 369 - 378
  • [62] Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a)
    Serrano, M
    Lin, AW
    McCurrach, ME
    Beach, D
    Lowe, SW
    [J]. CELL, 1997, 88 (05) : 593 - 602
  • [63] The INK4A/ARF locus and its two gene products
    Sharpless, NE
    DePinho, RA
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) : 22 - 30
  • [64] Cancer cell cycles
    Sherr, CJ
    [J]. SCIENCE, 1996, 274 (5293) : 1672 - 1677
  • [65] The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2
    Stott, FJ
    Bates, S
    James, MC
    McConnell, BB
    Starborg, M
    Brookes, S
    Palmero, I
    Ryan, K
    Hara, E
    Vousden, KH
    Peters, G
    [J]. EMBO JOURNAL, 1998, 17 (17) : 5001 - 5014
  • [66] P53-DEPENDENT APOPTOSIS SUPPRESSES TUMOR-GROWTH AND PROGRESSION IN-VIVO
    SYMONDS, H
    KRALL, L
    REMINGTON, L
    SAENZROBLES, M
    LOWE, S
    JACKS, T
    VANDYKE, T
    [J]. CELL, 1994, 78 (04) : 703 - 711
  • [67] P19ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
    Tao, WK
    Levine, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6937 - 6941
  • [68] RELEASE OF AN INHIBITOR OF ANGIOGENESIS UPON INDUCTION OF WILD-TYPE P53 EXPRESSION IN GLIOBLASTOMA CELLS
    VAN MEIR, EG
    POLVERINI, PJ
    CHAZIN, VR
    HUANG, HJS
    DETRIBOLET, N
    CAVENEE, WK
    [J]. NATURE GENETICS, 1994, 8 (02) : 171 - 176
  • [69] Wig-1, a new p53-induced gene encoding a zinc finger protein
    VarmehZiaie, S
    Okan, I
    Wang, YS
    Magnusson, KP
    Warthoe, P
    Strauss, M
    Wiman, KG
    [J]. ONCOGENE, 1997, 15 (22) : 2699 - 2704
  • [70] The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression
    Venot, C
    Maratrat, M
    Dureuil, C
    Conseiller, E
    Bracco, L
    Debussche, L
    [J]. EMBO JOURNAL, 1998, 17 (16) : 4668 - 4679